Clinical trial
Safety and Immunogenicity of Influenza Vaccine Among HIV-infected Young Subjects: Conventional Vaccine Versus Intradermal Vaccine
NCT02398097 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity of Influenza Vaccine Among HIV-infected Young Subjects: Conventional Vaccine Versus Intradermal Vaccine
- Lead sponsor
- Korea University Guro Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- April 30, 2012
- Enrollment
- 88 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
human influenza